Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Dapoxetine

Dapoxetine

Dapoxetine structure

Dapoxetine 

structure
  • CAS No:

    119356-77-3

  • Formula:

    C21H23NO

  • Chemical Name:

    Dapoxetine

  • Synonyms:

    Benzenemethanamine,N,N-dimethyl-α-[2-(1-naphthalenyloxy)ethyl]-,(αS)-;Benzenemethanamine,N,N-dimethyl-α-[2-(1-naphthalenyloxy)ethyl]-,(S)-;(αS)-N,N-Dimethyl-α-[2-(1-naphthalenyloxy)ethyl]benzenemethanamine;Dapoxetine;LY 210448;(S)-(+)-Dapoxetine;(S)-(+)-N,N-Dimethyl-α-[2-(1-naphthalenyloxy)ethyl]benzenemethanamine;(S)-(+)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine;(1S)-N,N-Dimethyl-3-naphthalen-1-yloxy-1-phenylpropan-1-amine

  • Categories:

    Active Pharmaceutical Ingredients  >  Circulatory System Drugs

Description

Premature ejaculation (PE) is the most common male sexual dysfunction. Dapoxetine hydrochloride,marketed as Priligy and Westoxetin, is a class of PE treatment drugs known as selective serotonin reuptake inhibitors (SSRI) , was the first drug originally approved for the on-demand treatment of men 18–64 years old with PE. Dapoxetine works by inhibiting the serotonin transporter, increasing serotonin's action at the post synaptic cleft, and as a result promoting ejaculatory delay.


Dapoxetine is a member of naphthalenes.|Dapoxetine is a selective serotonin reuptake inhibitor, for the treatment of premature ejaculation. In a phase II proof-of-concept study conducted by PPD, dapoxetine demonstrated a statistically significant increase in ejaculatory latency when compared to placebo. Alza submitted a NDA to the FDA for dapoxetine for the treatment of premature ejaculation in December 2004. In October 2005, the company received a FDA Non-Approvable letter from the FDA, at which time they planned to work with regulators to address outstanding questions.

Dapoxetine Basic Attributes

341.88

305.41

GB2433A4M3

DTXSID0057627

G04BX14|G - Genito urinary system and sex hormones

2922299090

Characteristics

12.5

5.13

1.081±0.06 g/cm3(Predicted)

454.4±38.0 °C(Predicted)

132.6±29.1 °C

1.607

Safety Information

P264, P270, P273, P280, P301+P312, P305+P351+P338, P330, P337+P313, P501

H302

|Warning|H302 (97.67%): Harmful if swallowed [Warning Acute toxicity, oral]|P264, P270, P273, P280, P301+P312, P305+P351+P338, P330, P337+P313, and P501|Aggregated GHS information provided by 43 companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

For the treatment of premature ejaculation.

Dapoxetine is a selective serotonin reuptake inhibitor currently undergoing trials through Alza (under license from GenuPro, a collaboration between Eli Lilly and PPD). Dapoxetine is a short-acting SSRI drug currently being considered for approval by the Food and Drug Administration (FDA) for the treatment of premature ejaculation in men, which would make it the first drug approved for such treatment. Despite two clinical trials finished in 2006, experts doubt it will be approved by the FDA soon because SSRIs come with undesirable side-effects after long-term use, such as psychiatric problems, dermatological reactions, increase in body weight, lower sex-drive, nausea, headache, upset stomach and weakness, thus not significantly outweighing the benefit of premature ejaculation medication versus the risks. By contrast with SSRIs approved for depression, which take 2 weeks or longer to reach steady-state concentration, dapoxetine has a unique pharmacokinetic profile, with a short time to maximum serum concentration (about 1 h) and rapid elimination (initial half-life of 1-2 h).

Rapidly absorbed.

Initial half-life of 1-2 hours.

The drug's mechanism of action is thought to be related to inhibition of neuronal reuptake of serotonin and subsequent potentiation of serotonin activity. The central ejaculatory neural circuit comprises spinal and cerebral areas that form a highly interconnected network. The sympathetic, parasympathetic, and somatic spinal centers, under the influence of sensory genital and cerebral stimuli integrated and processed at the spinal cord level, act in synergy to command physiologic events occurring during ejaculation. Experimental evidence indicates that serotonin (5-HT), throughout brain descending pathways, exerts an inhibitory role on ejaculation. To date, three 5-HT receptor subtypes (5-HT(1A), 5-HT(1B), and 5-HT(2C)) have been postulated to mediate 5-HT's modulating activity on ejaculation.

dapoxetine

Dapoxetine Use and Manufacturing

Antidepressant.White crystal powder with sweet taste and no odor, hygroscopic and soluble in water. It has a stable chemical property with the melting point at 175~177℃.Oral administration of one pill 20-30 mins before sexual intercourse; it can be taken irregularly; it’s better to take it with an empty stomach; avoid fatty food during administration; no tea before administration. Its effect is significant when the user under sexual stimulus.

Computed Properties

Molecular Weight:305.4
XLogP3:5.1
Hydrogen Bond Acceptor Count:2
Rotatable Bond Count:6
Exact Mass:305.177964357
Monoisotopic Mass:305.177964357
Topological Polar Surface Area:12.5
Heavy Atom Count:23
Complexity:337
Defined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Dapoxetine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.